Sinclair Pharma surges on acquisition talks

Sinclair Pharma admitted that it is in discussion about a potential "significant" product acquisition after its share price surged. "The company would expect to fund this acquisition substantially through an equity fundraising and it would be subject to shareholder approval," it said. Shares in the pharmaceutical firm are up 13% on the day and have risen over 25% in over a week. The group said the discussions are ongoing and there is no certainty about the final outcome.